Listen to The Lancet
by The Lancet
In conversation with... Tasdik Hasan
About this podcast
The Lancet (www.thelancet.com) is a weekly medical journal, renowned for the publication of high-quality peer-reviewed research and reviews from around the world. In the Podcasts our editors discuss journal highlights, including interviews with authors of key articles to provide context and insight to advancements in medicine and health worldwide.
Episodes
The newest 20 of 702 episodes
- In conversation with... Tasdik Hasan · 33 minA Health Policy piece in our April issue by Tasdik Hasan and co-authors titled: Co-designing a Bangla Mental Health Sign Language Bank in Bangladesh
- In conversation with... Mike Crawford · 33 minCan personality disorder treatments be reduced to just a few months?
- In conversation with... Thao Ha · 24 minIn this episode, co-hosted by our Senior Editor Amy Slogrove and our Lancet Child & Adolescent Health Youth Advisory Panel member, Matea Canizares, we discuss adolescent digital…
- In conversation with... Louise Chappell and Na'ama Carlin · 31 minThe uniqueness of each patient is at the heart of this year's World Cancer Day. In this Podcast you will hear from two cancer survivors about their unique experience with cancer…
- In conversation with... Susannah Stanway · 25 minIn Conversation with The Lancet returns with Dr Susannah Stanway, honorary consultant medical oncologist at the Royal Marsden and honorary clinical senior lecturer in Education…
- In conversation with... Franck Morschhauser · 14 minFranck Morschhauser joins Ben Abbott of The Lancet to discuss the phase 3 EPCORE FL-1 study on epcoritamab, lenalidomide, and rituximab for relapsed or refractory follicular…
- In conversation with... Arnon Kater and Sabina Kersting · 24 minProfessor Arnon Kater and Dr Sabina Kersting join us to discuss the results of their phase 2 trial testing a new first-line treatment regimen in chronic lymphocytic leukaemia…
- Carlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health · 1 h 1 minUltra-processed foods are on the rise. Despite the emphasis placed on individual responsibility, our deteriorating diets are primarily the result of the sophisticated political…
- In conversation with... Shun Lu · 21 minShun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung…
- In conversation with... Neal Shore · 23 minNeal Shore joins Ben Abbott of The Lancet to discuss the phase 3 POTOMAC trial of durvalumab plus BCG in BCG-naïve, high-risk non-muscle-invasive bladder cancer, which is being…
- The EAT-Lancet Commission on healthy, sustainable, and just food systems · 40 minWalter Willett, Shakuntala Thilsted and Johan Rockström discuss the second EAT-Lancet Commission report.
- In conversation with... Stephen Chan · 21 minStephen Chan joins Ben Abbott of The Lancet to discuss the key messages of the Lancet Commission on addressing the global hepatocellular carcinoma burden, which is published…
- In conversation with... Rebecca Fitzgerald · 28 minRebecca Fitzgerald joins us to discuss her recent prospective real-world implementation study of capsule sponge risk stratification in Barrett’s oesophagus surveillance in the UK.
- In conversation with... Changsong Qi · 15 minChangsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific…
- Francis Couturaud on treatment of venous thromboembolism · 29 minFrancis Couturaud joins Chloe Wilson of The Lancet to discuss the RENOVE trial, which looks at assessing the efficacy and safety of reduced-dose versus full-dose direct oral…
- How Trump is affecting health around the world · 39 minDonald Trump has taken office in the US and immediately turned his attention to dismantling the US position as a world leader in global health. How will actions taken so far…
- In conversation with... Michael Heneka · 22 minMichael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β…
- In conversation with... Nusrat Husain, Farah Lunat, and Fehmida Motala · 49 minROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal…
- In conversation with... Rasha Al-Lamee and Shayna Chotai on ESC 2024 · 40 minRasha Al-Lamee and Shayna Chotai join Chloe Wilson of The Lancet to discuss ESC Congress 2024 highlights.
- Self-harm · 36 minGavin is joined by Paul Moran and Helen Christensen to discuss The Lancet's new commission on self-harm, exploring its prevalence, cultural factors, and the crucial need for…








